FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37230691> ?p ?o ?g. }

• Q37230691 description "article científic" @default.
• Q37230691 description "article scientifique" @default.
• Q37230691 description "articolo scientifico" @default.
• Q37230691 description "artigo científico" @default.
• Q37230691 description "artículu científicu espublizáu en 2009" @default.
• Q37230691 description "bilimsel makale" @default.
• Q37230691 description "scientific article published on 13 February 2009" @default.
• Q37230691 description "vedecký článok" @default.
• Q37230691 description "vetenskaplig artikel" @default.
• Q37230691 description "videnskabelig artikel" @default.
• Q37230691 description "vědecký článek" @default.
• Q37230691 description "wetenschappelijk artikel" @default.
• Q37230691 description "wissenschaftlicher Artikel" @default.
• Q37230691 description "наукова стаття, опублікована в лютому 2009" @default.
• Q37230691 description "научни чланак" @default.
• Q37230691 description "مقالة علمية نشرت في 13 فبراير 2009" @default.
• Q37230691 name "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 name "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 name "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice." @default.
• Q37230691 type Item @default.
• Q37230691 label "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 label "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 label "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice." @default.
• Q37230691 prefLabel "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 prefLabel "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 prefLabel "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice." @default.
• Q37230691 P1433 Q37230691-E95556BB-4165-451C-9D0F-F7FC807BF163 @default.
• Q37230691 P1476 Q37230691-333F9803-F926-4B5A-867A-4119A6B0C281 @default.
• Q37230691 P2093 Q37230691-1239A80C-D2E9-4BE7-B5A2-6B0175EC18C0 @default.
• Q37230691 P2093 Q37230691-28568055-BAB9-49D6-9489-F1B8448F011F @default.
• Q37230691 P2093 Q37230691-37315D56-7E75-4734-814C-8C3E0B06C7F5 @default.
• Q37230691 P2093 Q37230691-B556AED6-5086-4505-94BF-18AF08963D2B @default.
• Q37230691 P2093 Q37230691-E17913ED-5EF9-4169-BC60-9857B1D281DD @default.
• Q37230691 P2093 Q37230691-E6C683CF-3887-4CD1-A859-18886F8433A6 @default.
• Q37230691 P2093 Q37230691-EC1F8E96-7BC8-4A91-9CE3-85668B9D4CFC @default.
• Q37230691 P2860 Q37230691-0049AD70-E3B6-4B48-8887-C2628C1B7ED2 @default.
• Q37230691 P2860 Q37230691-06163F6A-1DCB-4385-88A5-C703668506C0 @default.
• Q37230691 P2860 Q37230691-07BE324C-CA8B-4848-8697-DF7A356F290E @default.
• Q37230691 P2860 Q37230691-09674834-6098-4820-A2DA-6DC3C26EED9A @default.
• Q37230691 P2860 Q37230691-0A77DB17-05BB-4005-A02D-B5CC8F5A2757 @default.
• Q37230691 P2860 Q37230691-0CCE50C5-9141-4DEA-8943-6ECC6E1357DA @default.
• Q37230691 P2860 Q37230691-16D8DF92-261F-48A0-99B5-6BF5EC1308CB @default.
• Q37230691 P2860 Q37230691-1D43AD8B-2A95-4110-B97E-ECB544C321A8 @default.
• Q37230691 P2860 Q37230691-1FBB7C3B-8851-4251-B59B-A445642DAB8D @default.
• Q37230691 P2860 Q37230691-239CDF20-0B28-44AD-9F3E-C49BD5CDA1F4 @default.
• Q37230691 P2860 Q37230691-253CE65A-1E66-4B26-A61A-040A8A126A78 @default.
• Q37230691 P2860 Q37230691-26AEC2F0-0B58-4DC8-B833-DCA5525852D3 @default.
• Q37230691 P2860 Q37230691-294145C2-39D0-4F58-B52E-C177C7C5D013 @default.
• Q37230691 P2860 Q37230691-2BE3B913-6449-4144-91A0-03F92F0D755A @default.
• Q37230691 P2860 Q37230691-2D920DD1-4C0D-4ECC-8B05-2A92D37E7A0A @default.
• Q37230691 P2860 Q37230691-31E8388F-D339-417B-BC3D-38CBB5FD4AE1 @default.
• Q37230691 P2860 Q37230691-34CAD646-FB91-414F-AF50-5EB67EB1988E @default.
• Q37230691 P2860 Q37230691-3597B228-C883-4D38-80D8-4DEBFBB97655 @default.
• Q37230691 P2860 Q37230691-37DFC098-5530-4A55-B044-3A36FD585D71 @default.
• Q37230691 P2860 Q37230691-434990D4-3940-4F3D-B913-952A8B9DE15C @default.
• Q37230691 P2860 Q37230691-4521014A-28C5-4BD1-A65B-38E9B5ABCA99 @default.
• Q37230691 P2860 Q37230691-46F05100-C2E9-4871-A173-5A4DF3551B6C @default.
• Q37230691 P2860 Q37230691-4FCB7D05-509F-4917-8331-ED28D88BC211 @default.
• Q37230691 P2860 Q37230691-52243623-F5D8-460C-9B29-66829D7A6448 @default.
• Q37230691 P2860 Q37230691-63C299AA-383F-48A1-824E-78D4AA2E530F @default.
• Q37230691 P2860 Q37230691-6B4662C8-510E-4152-846C-B4C383E6A239 @default.
• Q37230691 P2860 Q37230691-6E786C19-9DB9-4D17-8DB4-0C10394CCE0A @default.
• Q37230691 P2860 Q37230691-6FB50C81-0DDB-4BFB-B87D-257B0B474044 @default.
• Q37230691 P2860 Q37230691-731E8262-8313-4CA9-80F3-2F0F0AF081EC @default.
• Q37230691 P2860 Q37230691-8DF077BD-BC14-4C58-BFC0-BCD453E7D946 @default.
• Q37230691 P2860 Q37230691-8EE79A5B-46D5-4F3E-82D0-1DB3BC43D50E @default.
• Q37230691 P2860 Q37230691-91339D17-358F-42ED-AB33-486382A81B79 @default.
• Q37230691 P2860 Q37230691-9653B313-6FDF-4B74-8AD4-3DB76F75413D @default.
• Q37230691 P2860 Q37230691-9711EB7B-573A-4EB6-AE90-86A5BBC38D22 @default.
• Q37230691 P2860 Q37230691-A3B27D6C-594E-48DB-A86F-4EF6B60BF1F0 @default.
• Q37230691 P2860 Q37230691-B2875233-62CD-4CFF-AF39-F4B42A93C753 @default.
• Q37230691 P2860 Q37230691-C6811F70-F083-4BD2-9864-3732355DA3AF @default.
• Q37230691 P2860 Q37230691-C79996C9-D067-4C10-AD0E-68B468CCFCDE @default.
• Q37230691 P2860 Q37230691-C922B222-A4BB-44D1-8087-895E07B4BE0C @default.
• Q37230691 P2860 Q37230691-D278E8E8-D4DD-442C-B1E8-7F0DA2935BD2 @default.
• Q37230691 P2860 Q37230691-D7560E16-6E85-4494-AE2C-C35074F75FE3 @default.
• Q37230691 P2860 Q37230691-E6F38088-7D4A-4C48-9C30-61DB164BFE23 @default.
• Q37230691 P2860 Q37230691-EAEB6087-5712-4AD4-96C7-F0B631BB8FE8 @default.
• Q37230691 P2860 Q37230691-EB8DDB81-C720-4574-9FFE-114165F844C7 @default.
• Q37230691 P2860 Q37230691-F393B6F4-9B2E-4C34-9071-52157C257E40 @default.
• Q37230691 P2860 Q37230691-F39EEFFD-3E5F-4DD0-BC70-C8EB3E23E3F0 @default.
• Q37230691 P2860 Q37230691-F8699C92-6368-4424-A9AD-A780330ABD59 @default.
• Q37230691 P2860 Q37230691-FC2D79DB-DD3A-478A-AF88-76411DAB0898 @default.
• Q37230691 P2860 Q37230691-FED8854C-294A-4D27-BFF5-CAC63EAB6E1C @default.
• Q37230691 P304 Q37230691-B464A0F2-012A-4DDB-88E7-A057601C4B41 @default.
• Q37230691 P31 Q37230691-297E2918-D5C6-45FB-B9D1-24764A05F418 @default.
• Q37230691 P356 Q37230691-8BDAE905-A2A8-4085-BB02-EE1A103CF6A6 @default.
• Q37230691 P407 Q37230691-4C2C7793-D896-4FA2-9ACC-AD6B26EF918A @default.
• Q37230691 P433 Q37230691-F2BD6724-C61D-4CA0-894D-76601568D524 @default.
• Q37230691 P478 Q37230691-04C98DFC-3AE3-43EB-8D93-FFD09B905449 @default.
• Q37230691 P577 Q37230691-8FD5170D-518E-4D56-BB66-17754DC87ACA @default.
• Q37230691 P5875 Q37230691-76481007-1B11-4D78-9546-7968FF658486 @default.
• Q37230691 P698 Q37230691-6460FFA4-FA1B-4195-B9A4-2302049B6CF6 @default.
• Q37230691 P921 Q37230691-0E26723B-E9E0-4280-8C6A-92EB560DBC6F @default.
• Q37230691 P932 Q37230691-34E624D8-AE50-47F9-80B3-A44243AF10B0 @default.
• Q37230691 P356 J.1476-5381.2008.00109.X @default.
• Q37230691 P698 19220285 @default.
• Q37230691 P1433 Q919631 @default.
• Q37230691 P1476 "The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice" @default.
• Q37230691 P2093 "E Lundholm" @default.

• next